The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model

Nephrology Dialysis Transplantation

Volumn 13, Issue 9, 1998, Pages 2210-2215

  Bellizzi, Vincenzo ^a   Sabbatini, Massimo ^a   Fuiano, Giorgio ^b   Sansone, Gennaro ^a   Magri, Paola ^a   Uccello, Francesco ^a   Andreucci, Michele ^a   De Nicola, Luca ^a   Cianciaruso, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Erythropoietin; Haematocrit; Morphometry; Progression of renal failure; Proteinuria; Remnant kidney model rats

Indexed keywords

PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HEMATOCRIT; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY HYPERTROPHY; MALE; MESANGIUM CELL; NEPHRECTOMY; NONHUMAN; PHLEBOTOMY; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; BLOOD PRESSURE; CREATININE; ERYTHROPOIETIN; HEMATOCRIT; HUMANS; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REFERENCE VALUES; TIME FACTORS;

EID: 0031697911     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.9.2210     Document Type: Article

References (30)

1. Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int 1985; 18: 1-5
2. The US Recombinant Human Erythropoietin Predialysis Study Group. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 1991; 18: 50-59
3. Lim VS, DeGowin RL, Zavala D. Recombinant human erythropoietin treatment in predialysis patients. Ann Intern Med 1989; 110: 108-114
4. Revicki DA, Brown RE, Feeny DH et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995; 25: 548-554
5. Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 1996; 28: 53-61
6. Levin A, Singer J, Thompson CR et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347 354
7. Eschbach JW, The future of rHuEpo. Nephrol Dial Transplant 1995; 10: 96-109
8. Jacobs C, Starting rHuEpo in chronic renal failure: when, why and how? Nephrol Dial Transplant 1995: 10: 43-47
9. NKF-DOQI Clinical Practice Guidelines for the treatment of anemia of chronic renal failure: II. Target hematocrit/hemoglobin. Am J Kidney Dis 1997; 30: S199 201
10. Watson AJ, Gimenez LF, Cotton S et al. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin. Am J Med 1990; 89: 432-435
11. Austrian Multicenter Study Group of r-Hu-Epo in Predialysis Patients. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Nephron 1992; 61: 399-403
12. Roth D, Smith RD, Schulman G et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure in predialysis patients. Am J Kidney Dis 1994; 24: 777-784
13. Krmar RT, Gretz N, Klare B, Wuhl E, Scharer K. Renal function in predialysis children with chronic renal failure treated with erythropoietin. Pediatr Nephrol 1997; 11: 69 73
14. Floege J, Alpers CE, Burns MW et al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-497
15. Garcia DL, Anderson S, Rennke HG, Brenner BM. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci USA 1988; 85:6142-6146
16. Lafferty HM, Garcia DL, Rennke HG et al. Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension. J Am Soc Nephrol 1991; 1: 1180-1185
17. Stockenhuber F, Kurz RW, Geissler K et al. Recombinant human erythropoietin activates a broad spectrum of progenitors cells. Kidney Int 1990; 37: 150-156
18. Horina JH, Schmid CR, Roob JM et al. Bone marrow changes following treatment of renal anemia with erythropoietin. Kidney Int 1991; 40: 917-922
19. Anagnostou A, Sun Lee E, Kessimian N et al. Erythropoietin has mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1991; 87: 5978-5982
20. Bellizzi V, De Nicola L, Ames P et al. Fetal proteins and chronic treatment with low-dose erythropoietin. J Lab Clin Med 1997; 129: 193-199
21. Gretz N, Waldherr R, Strauch M. The remnant kidney model. In: Gretz N, Strauch M, eds. Experimental and Genetic Rat Models of Chronic Renal Failure. Karger, Basel, 1993; 1-28
22. Griffin KA, Picken M, Bidani AK. Methods of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 1994; 4: 2023-2031
23. Dal Canton A, Altomonte M, Conte G et al. Glomerular dynamics and salt balance in pregnant rats with renal hypertension. Am J Physiol 1989; 256: F728-F734
24. Allen DE, Dowling JP. Techniques for nephropathology. Boca Raton, Fl, C.R.C. Press 1981; 1-117
25. Nadasdy T, Silva FG, Hogg RS. Minimal change nephrotic sindrome. Focal sclerosis complex (including IgM nephropathy and diffuse mesangial hypercellularity). In: Tisher CC, Brenner BM, ed. Renal Pathology, 2nd edn. Lippincott. Philadelphia, 1994; 331-390
26. Conte G, Dal Canton A, Fuiano G et al. Mechanism of impaired urinary concentration in chronic primary glomerulonephritis. Kidney Int 1985; 27: 792-798
27. Elias H, Henning A, Schwartz DE. Sterology: applications to biomedical research. Physiol Rev 1971; 51: 158-200
28. Hirose K, Osterby R, Nozawa M, Gundersen HJG. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982; 21: 689-695
29. Simons JL, Provoost AP, Anderson S et al. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994; 46: 396-404
30. Lax DS, Benstein JA, Tolbert E, Dworkin LD. Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 1990; 41: 1527-1534